| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.706 | 0.004 | 0.706 | Mcl-1 antagonist | 0.134 0.107 CID_97535 | ||
| 0.57 | 0.019 | 0.57 | Thioredoxin glutathione reductase inhibitor | |||
| 0.527 | 0.021 | 0.527 | Aryl hydrocarbon receptor agonist | |||
| 0.512 | 0.018 | 0.512 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.511 | 0.021 | 0.518 | Calpain 2 inhibitor | 0.518 0.019 CID_97535 | CID_97535 | |
| 0.492 | 0.014 | 0.67 | Superoxide dismutase inhibitor | 0.67 0.005 CID_97535 0.318 0.045 CID_154699513 | CID_97535 | |
| 0.499 | 0.028 | 0.499 | Streptokinase A inhibitor | |||
| 0.521 | 0.052 | 0.521 | Caspase 9 stimulant | |||
| 0.452 | 0.011 | 0.452 | Calcium channel activator | |||
| 0.458 | 0.039 | 0.458 | GABA C receptor rho-3 antagonist | |||
| 0.454 | 0.05 | 0.454 | 5 Hydroxytryptamine release inhibitor | |||
| 0.403 | 0.013 | 0.403 | Dual specificity phosphatase 3 inhibitor | |||
| 0.472 | 0.084 | 0.472 | Transcription factor inhibitor | |||
| 0.477 | 0.089 | 0.477 | DNA directed DNA polymerase inhibitor | |||
| 0.392 | 0.005 | 0.392 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.476 | 0.093 | 0.476 | DNA polymerase beta inhibitor | |||
| 0.411 | 0.036 | 0.411 | 12-Lipoxygenase inhibitor | |||
| 0.439 | 0.069 | 0.439 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.36 | 0.004 | 0.36 | Nitric-oxide synthase stimulant | |||
| 0.443 | 0.098 | 0.443 | Alpha-glucosidase inhibitor | |||
| 0.403 | 0.066 | 0.403 | Prostaglandin dehydrogenase inhibitor | |||
| 0.335 | 0.004 | 0.335 | Triose-phosphate isomerase inhibitor | |||
| 0.333 | 0.004 | 0.333 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.349 | 0.021 | 0.349 | Dual specificity phosphatase inhibitor | |||
| 0.331 | 0.005 | 0.331 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.249 0.01 CID_97535 0.265 0.008 CID_154699513 | ||
| 0.329 | 0.007 | 0.329 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.329 | 0.007 | 0.329 | Succinate dehydrogenase inhibitor | |||
| 0.327 | 0.009 | 0.327 | UDP-glucose 4-epimerase inhibitor | |||
| 0.322 | 0.005 | 0.322 | Potassium channel (Ca-activated) activator | |||
| 0.332 | 0.015 | 0.332 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.326 | 0.011 | 0.326 | Heat shock protein 90 alpha antagonist | |||
| 0.386 | 0.083 | 0.448 | Histamine release inhibitor | 0.448 0.051 CID_97535 0.224 0.177 CID_154699513 | CID_97535 | |
| 0.304 | 0.004 | 0.304 | Potassium channel activator | |||
| 0.293 | 0.004 | 0.293 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.321 | 0.035 | 0.321 | Sigma receptor agonist | |||
| 0.393 | 0.117 | 0.422 | Apoptosis agonist | 0.422 0.104 CID_97535 | CID_97535 | |
| 0.293 | 0.02 | 0.293 | Cytidine deaminase inhibitor | |||
| 0.272 | 0.003 | 0.272 | Thioredoxin reductase inhibitor | 0.08 0.063 CID_97535 | ||
| 0.283 | 0.014 | 0.283 | Alkaline phosphatase inhibitor | |||
| 0.288 | 0.031 | 0.288 | Non-steroidal antiinflammatory agent | |||
| 0.252 | 0.005 | 0.252 | Potassium channel large-conductance Ca-activated activator | |||
| 0.284 | 0.037 | 0.284 | Anesthetic general | |||
| 0.319 | 0.073 | 0.319 | Vasodilator, coronary | |||
| 0.252 | 0.006 | 0.252 | Urease inhibitor | 0.116 0.049 CID_97535 | ||
| 0.25 | 0.009 | 0.25 | NMDA receptor antagonist | 0.088 0.056 CID_97535 | ||
| 0.254 | 0.015 | 0.254 | Glutamate receptor antagonist | |||
| 0.242 | 0.006 | 0.242 | NMDA 2 receptor antagonist | |||
| 0.236 | 0.004 | 0.236 | Bcl2 antagonist | 0.125 0.009 CID_97535 0.078 0.034 CID_154699513 | ||
| 0.232 | 0.004 | 0.232 | NMDA receptor subunit 3B antagonist | |||
| 0.273 | 0.046 | 0.331 | Calpain inhibitor | 0.331 0.021 CID_97535 0.208 0.106 CID_154699513 | CID_97535 | |
| 0.23 | 0.005 | 0.23 | Thioredoxin inhibitor | 0.135 0.023 CID_97535 | ||
| 0.234 | 0.009 | 0.234 | CF transmembrane conductance regulator agonist | |||
| 0.226 | 0.003 | 0.226 | Glutamate (mGluR4) agonist | |||
| 0.227 | 0.004 | 0.227 | Glutamate (mGluR group III) agonist | |||
| 0.28 | 0.057 | 0.28 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.251 | 0.028 | 0.251 | Amylase inhibitor | |||
| 0.225 | 0.004 | 0.225 | VCAM antagonist | 0.045 0.014 CID_97535 | ||
| 0.224 | 0.004 | 0.224 | VCAM-1 antagonist | 0.045 0.014 CID_97535 | ||
| 0.262 | 0.042 | 0.262 | DNA methyltransferase I inhibitor | 0.198 0.07 CID_97535 | ||
| 0.243 | 0.029 | 0.243 | Histone acetyltransferase inhibitor | |||
| 0.217 | 0.004 | 0.217 | NMDA 2A receptor antagonist | 0.114 0.01 CID_97535 0.08 0.02 CID_154699513 | ||
| 0.229 | 0.026 | 0.229 | NADPH oxidase inhibitor | |||
| 0.228 | 0.027 | 0.228 | Heat shock protein 90 antagonist | |||
| 0.263 | 0.065 | 0.263 | Gastrin inhibitor | 0.253 0.076 CID_97535 | ||
| 0.207 | 0.009 | 0.207 | Creatine kinase inhibitor | |||
| 0.24 | 0.047 | 0.24 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.204 | 0.012 | 0.204 | Interleukin 8 antagonist | |||
| 0.263 | 0.074 | 0.263 | Transcription factor STAT3 inhibitor | 0.246 0.087 CID_97535 | ||
| 0.198 | 0.012 | 0.198 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.206 | 0.021 | 0.206 | Cathepsin H inhibitor | 0.151 0.045 CID_97535 0.108 0.093 CID_154699513 | ||
| 0.213 | 0.029 | 0.213 | Hexokinase inhibitor | |||
| 0.197 | 0.015 | 0.284 | Adenylate kinase inhibitor | 0.284 0.008 CID_97535 0.178 0.019 CID_154699513 | CID_97535 | |
| 0.195 | 0.013 | 0.565 | Histidine decarboxylase inhibitor | 0.565 0.002 CID_97535 0.491 0.003 CID_154699513 | CID_97535 | |
| 0.238 | 0.057 | 0.238 | RNA-directed DNA polymerase inhibitor | |||
| 0.249 | 0.069 | 0.249 | Tyrosine 3 hydroxylase inhibitor | 0.188 0.158 CID_97535 0.184 0.166 CID_154699513 | ||
| 0.21 | 0.031 | 0.21 | Toll-Like receptor 9 antagonist | |||
| 0.18 | 0.004 | 0.18 | D-Ala-D-Ala ligase inhibitor | |||
| 0.178 | 0.004 | 0.213 | Kainate receptor antagonist | 0.213 0.004 CID_97535 0.096 0.008 CID_154699513 | CID_97535 | |
| 0.251 | 0.078 | 0.257 | Interleukin agonist | 0.253 0.076 CID_97535 0.257 0.074 CID_154699513 | CID_154699513 | |
| 0.173 | 0.003 | 0.173 | NMDA receptor glycine site antagonist | |||
| 0.204 | 0.035 | 0.204 | Cytokine production inhibitor | |||
| 0.229 | 0.061 | 0.229 | DNA methylase inhibitor | 0.207 0.075 CID_97535 | ||
| 0.216 | 0.048 | 0.216 | Amyloid beta precursor protein antagonist | |||
| 0.175 | 0.008 | 0.175 | T cell inhibitor | |||
| 0.176 | 0.011 | 0.176 | DOPA decarboxylase inhibitor | |||
| 0.168 | 0.005 | 0.168 | NMDA receptor subunit 3A antagonist | |||
| 0.167 | 0.005 | 0.167 | AMPA receptor antagonist | 0.064 0.023 CID_97535 0.044 0.037 CID_154699513 | ||
| 0.188 | 0.025 | 0.188 | Ferrochelatase inhibitor | |||
| 0.298 | 0.137 | 0.392 | Antibacterial | 0.392 0.081 CID_97535 0.219 0.208 CID_154699513 | CID_97535 | |
| 0.272 | 0.112 | 0.272 | Vasodilator, peripheral | |||
| 0.215 | 0.055 | 0.562 | Peroxidase inhibitor | 0.562 0.005 CID_97535 0.513 0.009 CID_154699513 | CID_97535 | |
| 0.248 | 0.088 | 0.248 | Transcription factor STAT inhibitor | 0.193 0.148 CID_97535 | ||
| 0.173 | 0.014 | 0.173 | CDK3/cyclin E inhibitor | |||
| 0.174 | 0.017 | 0.174 | Calcium antagonist | |||
| 0.179 | 0.025 | 0.179 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.158 | 0.004 | 0.158 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.165 | 0.014 | 0.165 | Toll-Like receptor 4 antagonist | 0.101 0.068 CID_97535 | ||
| 0.174 | 0.023 | 0.174 | Pregnane X receptor agonist | |||
| 0.16 | 0.01 | 0.959 | Glutathione S-transferase inhibitor | 0.959 0.001 CID_97535 0.433 0.002 CID_154699513 | CID_97535 | |
| 0.158 | 0.009 | 0.158 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.176 | 0.028 | 0.616 | Aminopeptidase B inhibitor | 0.616 0.002 CID_97535 0.423 0.004 CID_154699513 | CID_97535 | |
| 0.171 | 0.022 | 0.171 | Carbonic anhydrase III inhibitor | |||
| 0.166 | 0.019 | 0.166 | Beta glucuronidase inhibitor | |||
| 0.163 | 0.017 | 0.163 | Phosphodiesterase 7B inhibitor | |||
| 0.148 | 0.004 | 0.148 | NMDA receptor glycine site agonist | 0.071 0.035 CID_97535 | ||
| 0.169 | 0.026 | 0.169 | 5 Hydroxytryptamine 3A agonist | |||
| 0.189 | 0.047 | 0.189 | ATPase inhibitor | |||
| 0.145 | 0.003 | 0.145 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.163 | 0.023 | 0.163 | TRPA1 agonist | |||
| 0.18 | 0.041 | 0.18 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.185 | 0.045 | 0.265 | Neurotensin receptor agonist | 0.265 0.019 CID_97535 0.196 0.037 CID_154699513 | CID_97535 | |
| 0.171 | 0.033 | 0.171 | Cystathionine beta-synthase inhibitor | |||
| 0.185 | 0.048 | 0.185 | Arachidonic acid antagonist | |||
| 0.178 | 0.041 | 0.183 | Cell wall synthesis inhibitor | 0.183 0.038 CID_97535 0.169 0.049 CID_154699513 | CID_97535 | |
| 0.228 | 0.091 | 0.228 | Aldehyde oxidase inhibitor | |||
| 0.145 | 0.009 | 0.165 | NMDA receptor agonist | 0.165 0.006 CID_97535 0.136 0.01 CID_154699513 | CID_97535 | |
| 0.221 | 0.087 | 0.221 | Neuropeptide Y2 antagonist | 0.205 0.11 CID_97535 | ||
| 0.153 | 0.02 | 0.153 | Porphobilinogen synthase inhibitor | |||
| 0.227 | 0.095 | 0.227 | DNA damaging | |||
| 0.198 | 0.065 | 0.198 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.139 | 0.008 | 0.139 | NMDA 2C receptor antagonist | 0.113 0.012 CID_97535 0.065 0.038 CID_154699513 | ||
| 0.144 | 0.013 | 0.144 | Interleukin 5 antagonist | |||
| 0.141 | 0.01 | 0.141 | Biliverdin reductase inhibitor | |||
| 0.16 | 0.03 | 0.16 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.143 | 0.013 | 0.143 | Prostaglandin-E synthase inhibitor | |||
| 0.133 | 0.005 | 0.133 | GABA B receptor agonist | |||
| 0.137 | 0.009 | 0.137 | Purinergic P2X1 antagonist | |||
| 0.131 | 0.004 | 0.131 | Catechol O-methyltransferase inhibitor | |||
| 0.137 | 0.011 | 0.137 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.128 | 0.004 | 0.155 | AMPA 1 receptor antagonist | 0.111 0.005 CID_97535 0.155 0.004 CID_154699513 | CID_154699513 | |
| 0.179 | 0.056 | 0.179 | Interleukin 6 antagonist | 0.135 0.114 CID_97535 | ||
| 0.134 | 0.011 | 0.134 | GABA aminotransferase inhibitor | |||
| 0.162 | 0.04 | 0.162 | Interleukin 4 antagonist | |||
| 0.146 | 0.024 | 0.146 | Androgen antagonist | |||
| 0.124 | 0.003 | 0.124 | Potassium channel (Inward rectifier) activator | |||
| 0.167 | 0.047 | 0.167 | Calcium channel blocker | |||
| 0.132 | 0.012 | 0.132 | Alcohol oxidase inhibitor | |||
| 0.122 | 0.002 | 0.122 | Glutamate (mGluR8) agonist | 0.081 0.004 CID_97535 0.047 0.014 CID_154699513 | ||
| 0.122 | 0.003 | 0.122 | Potassium channel (ATP-sensitive) activator | |||
| 0.139 | 0.021 | 0.139 | MAP kinase kinase 1 inhibitor | |||
| 0.122 | 0.004 | 0.122 | Kainate receptor 2 antagonist | 0.054 0.014 CID_97535 0.045 0.019 CID_154699513 | ||
| 0.122 | 0.004 | 0.122 | Sodium/calcium exchanger inhibitor | |||
| 0.159 | 0.042 | 0.159 | Aldehyde dehydrogenase inhibitor | |||
| 0.153 | 0.036 | 0.153 | Ca2+-transporting ATPase inhibitor | |||
| 0.243 | 0.128 | 0.243 | Thyroid hormone antagonist | |||
| 0.195 | 0.081 | 0.195 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.157 | 0.043 | 0.157 | Cyclooxygenase 3 inhibitor | |||
| 0.123 | 0.01 | 0.123 | Androgen agonist | |||
| 0.15 | 0.039 | 0.15 | Alpha 2b adrenoreceptor antagonist | |||
| 0.132 | 0.023 | 0.132 | NADH dehydrogenase inhibitor | |||
| 0.145 | 0.036 | 0.145 | GABA C receptor agonist | |||
| 0.236 | 0.127 | 0.236 | Thyroid hormone beta antagonist | |||
| 0.142 | 0.037 | 0.142 | Protein kinase (CK2) inhibitor | |||
| 0.156 | 0.052 | 0.156 | Toll-Like receptor antagonist | |||
| 0.214 | 0.111 | 0.214 | 5 Hydroxytryptamine release stimulant | |||
| 0.105 | 0.003 | 0.105 | Nerve growth factor antagonist | |||
| 0.109 | 0.007 | 0.109 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.158 | 0.056 | 0.158 | MAP kinase 3 inhibitor | |||
| 0.111 | 0.011 | 0.111 | Phosphorylase inhibitor | |||
| 0.116 | 0.017 | 0.116 | Calcium channel L-type blocker | |||
| 0.116 | 0.017 | 0.116 | Carbonic anhydrase XII inhibitor | |||
| 0.111 | 0.014 | 0.111 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.103 | 0.006 | 0.103 | MDM2 inhibitor | |||
| 0.105 | 0.008 | 0.105 | Botulinum neurotoxin type A inhibitor | 0.083 0.015 CID_97535 0.06 0.037 CID_154699513 | ||
| 0.233 | 0.138 | 0.233 | Cholesterol antagonist | |||
| 0.123 | 0.028 | 0.123 | Carbonic anhydrase XIII inhibitor | |||
| 0.127 | 0.033 | 0.127 | DNA directed RNA polymerase inhibitor | |||
| 0.207 | 0.113 | 0.207 | DNA synthesis inhibitor | |||
| 0.128 | 0.034 | 0.128 | Breast cancer-resistant protein inhibitor | |||
| 0.25 | 0.157 | 0.25 | Beta lactamase inhibitor | |||
| 0.13 | 0.038 | 0.154 | Multidrug resistance-associated protein 1 inhibitor | 0.1 0.079 CID_97535 0.154 0.023 CID_154699513 | CID_154699513 | |
| 0.103 | 0.011 | 0.103 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.183 | 0.091 | 0.183 | Pyruvate kinase inhibitor | |||
| 0.114 | 0.023 | 0.114 | Carbonic anhydrase inhibitor | 0.072 0.039 CID_97535 | ||
| 0.109 | 0.018 | 0.109 | Carbonic anhydrase IX inhibitor | |||
| 0.179 | 0.089 | 0.179 | Death-associated protein kinase 3 inhibitor | |||
| 0.119 | 0.029 | 0.119 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.112 | 0.023 | 0.112 | Glycine receptor antagonist | |||
| 0.205 | 0.117 | 0.551 | Immunostimulant | 0.551 0.023 CID_97535 0.461 0.035 CID_154699513 | CID_97535 | |
| 0.191 | 0.103 | 0.191 | Dyrk kinase inhibitor | |||
| 0.114 | 0.027 | 0.114 | Phosphofructokinase-1 inhibitor | 0.069 0.048 CID_97535 | ||
| 0.096 | 0.011 | 0.096 | Exportin-1 inhibitor | |||
| 0.153 | 0.069 | 0.153 | GABA C receptor rho-2 antagonist | |||
| 0.096 | 0.012 | 0.096 | Fatty acid synthase inhibitor | |||
| 0.138 | 0.054 | 0.243 | Alkylator | 0.243 0.017 CID_97535 0.128 0.061 CID_154699513 | CID_97535 | |
| 0.133 | 0.05 | 0.133 | DNA repair enzyme inhibitor | |||
| 0.1 | 0.017 | 0.1 | Vanilloid 4 agonist | |||
| 0.165 | 0.082 | 0.165 | Tumour necrosis factor antagonist | |||
| 0.104 | 0.023 | 0.104 | Carbonic anhydrase VA inhibitor | |||
| 0.086 | 0.005 | 0.086 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.089 | 0.009 | 0.089 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.105 | 0.025 | 0.105 | Carbonic anhydrase V inhibitor | |||
| 0.161 | 0.082 | 0.161 | Catenin beta inhibitor | |||
| 0.096 | 0.017 | 0.096 | Glutamate (mGluR1) antagonist | |||
| 0.137 | 0.058 | 0.137 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.086 | 0.008 | 0.086 | Dihydroorotate oxidase inhibitor | |||
| 0.122 | 0.045 | 0.122 | Acetylcholine release stimulant | |||
| 0.093 | 0.016 | 0.093 | Phosphodiesterase VII inhibitor | |||
| 0.148 | 0.07 | 0.25 | Thiol protease inhibitor | 0.25 0.026 CID_97535 0.174 0.052 CID_154699513 | CID_97535 | |
| 0.11 | 0.033 | 0.11 | Bcr-Abl kinase inhibitor | |||
| 0.098 | 0.022 | 0.098 | Aromatase inhibitor | |||
| 0.183 | 0.108 | 0.183 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.084 | 0.01 | 0.121 | Bcl-xL inhibitor | 0.121 0.005 CID_97535 0.078 0.013 CID_154699513 | CID_97535 | |
| 0.108 | 0.035 | 0.108 | Carbonic anhydrase VI inhibitor | |||
| 0.102 | 0.029 | 0.263 | Glutamate dehydrogenase inhibitor | 0.263 0.007 CID_97535 0.233 0.008 CID_154699513 | CID_97535 | |
| 0.143 | 0.07 | 0.143 | Ribosomal protein S6 kinase inhibitor | |||
| 0.084 | 0.012 | 0.084 | Calcium channel P-type blocker | |||
| 0.079 | 0.008 | 0.079 | Collagenase inhibitor | 0.069 0.01 CID_97535 0.053 0.025 CID_154699513 | ||
| 0.078 | 0.007 | 0.078 | Phosphodiesterase 7A inhibitor | |||
| 0.083 | 0.012 | 0.083 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.079 | 0.008 | 0.173 | Thymidylate synthase inhibitor | 0.173 0.003 CID_97535 0.077 0.008 CID_154699513 | CID_97535 | |
| 0.16 | 0.089 | 0.436 | Phospholipase C inhibitor | 0.436 0.008 CID_97535 0.31 0.017 CID_154699513 | CID_97535 | |
| 0.075 | 0.004 | 0.075 | Kainate receptor 5 antagonist | 0.025 0.012 CID_97535 | ||
| 0.078 | 0.009 | 0.078 | Glutamate (mGluR4) antagonist | 0.049 0.022 CID_97535 | ||
| 0.187 | 0.118 | 0.373 | Peptidyltransferase inhibitor | 0.317 0.019 CID_97535 0.373 0.009 CID_154699513 | CID_154699513 | |
| 0.112 | 0.043 | 0.112 | Electrolyte absorption antagonist | |||
| 0.171 | 0.103 | 0.171 | MAP kinase kinase 2 inhibitor | |||
| 0.083 | 0.015 | 0.083 | Transcription factor RelA inhibitor | |||
| 0.11 | 0.042 | 0.14 | Alcohol dehydrogenase inhibitor | 0.14 0.024 CID_97535 0.107 0.045 CID_154699513 | CID_97535 | |
| 0.089 | 0.022 | 0.089 | Carbonic anhydrase II inhibitor | 0.055 0.039 CID_97535 | ||
| 0.113 | 0.046 | 0.113 | Anabolic | |||
| 0.116 | 0.05 | 0.116 | Carbonic anhydrase XV inhibitor | |||
| 0.07 | 0.004 | 0.07 | Heme oxygenase inhibitor | |||
| 0.084 | 0.02 | 0.442 | Ornithine carbamoyltransferase inhibitor | 0.442 0.003 CID_97535 0.19 0.007 CID_154699513 | CID_97535 | |
| 0.07 | 0.006 | 0.07 | Potassium channel Kv1.1 blocker | |||
| 0.068 | 0.005 | 0.068 | NMDA 2D receptor antagonist | |||
| 0.086 | 0.023 | 0.086 | Carbonic anhydrase I inhibitor | |||
| 0.104 | 0.042 | 0.104 | Bile acid receptor antagonist | |||
| 0.121 | 0.059 | 0.121 | Transcription factor STAT6 inhibitor | |||
| 0.139 | 0.079 | 0.139 | Heat shock protein 70 antagonist | |||
| 0.081 | 0.021 | 0.096 | Nitric oxide donor | 0.096 0.01 CID_97535 0.079 0.023 CID_154699513 | CID_97535 | |
| 0.144 | 0.086 | 0.144 | Interferon gamma antagonist | |||
| 0.118 | 0.059 | 0.118 | Calcium channel (voltage-sensitive) blocker | |||
| 0.104 | 0.048 | 0.104 | Potassium channel (Voltage-sensitive) activator | |||
| 0.062 | 0.005 | 0.062 | Kainate receptor 4 antagonist | 0.03 0.014 CID_97535 0.023 0.019 CID_154699513 | ||
| 0.095 | 0.039 | 0.103 | 3C-Like protease (SARS coronavirus) inhibitor | 0.103 0.03 CID_97535 | CID_97535 | |
| 0.126 | 0.07 | 0.126 | c-Src kinase inhibitor | |||
| 0.062 | 0.006 | 0.062 | Integrin alpha2 antagonist | |||
| 0.124 | 0.07 | 0.124 | MAP kinase kinase inhibitor | |||
| 0.066 | 0.011 | 0.066 | Purinergic P2X4 antagonist | |||
| 0.143 | 0.089 | 0.143 | Src kinase inhibitor | |||
| 0.079 | 0.026 | 0.079 | Argininosuccinate synthase inhibitor | 0.077 0.027 CID_97535 0.056 0.04 CID_154699513 | ||
| 0.167 | 0.116 | 0.167 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.116 | 0.065 | 0.166 | Caspase 3 inhibitor | 0.166 0.019 CID_97535 0.102 0.088 CID_154699513 | CID_97535 | |
| 0.061 | 0.01 | 0.061 | Dihydrofolate reductase inhibitor | |||
| 0.069 | 0.019 | 0.069 | Ryanodine receptor antagonist | |||
| 0.117 | 0.069 | 0.117 | Anesthetic local | |||
| 0.057 | 0.009 | 0.057 | Kainate receptor agonist | 0.04 0.031 CID_97535 | ||
| 0.111 | 0.063 | 0.111 | GABA C receptor antagonist | |||
| 0.058 | 0.011 | 0.076 | AMPA 4 receptor antagonist | 0.076 0.007 CID_97535 0.057 0.011 CID_154699513 | CID_97535 | |
| 0.056 | 0.01 | 0.056 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.056 | 0.01 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.092 | 0.047 | 0.092 | Platelet growth factor antagonist | |||
| 0.049 | 0.004 | 0.049 | Human T-cell leukemia virus type I protease inhibitor | 0.019 0.017 CID_97535 | ||
| 0.106 | 0.061 | 0.106 | Alpha 2c adrenoreceptor antagonist | |||
| 0.05 | 0.005 | 0.05 | Kainate receptor 1 antagonist | 0.037 0.008 CID_97535 | ||
| 0.056 | 0.012 | 0.056 | Phosphoglycerate kinase inhibitor | |||
| 0.058 | 0.014 | 0.058 | GABA B receptor antagonist | |||
| 0.061 | 0.019 | 0.061 | Carbonic anhydrase IV inhibitor | 0.053 0.023 CID_97535 | ||
| 0.049 | 0.007 | 0.049 | Cyclophilin A inhibitor | |||
| 0.058 | 0.016 | 0.058 | CDK5/p25 inhibitor | |||
| 0.134 | 0.093 | 0.134 | Neuropeptide Y1 antagonist | |||
| 0.083 | 0.042 | 0.451 | Glutamate decarboxylase inhibitor | 0.451 0.003 CID_97535 0.365 0.003 CID_154699513 | CID_97535 | |
| 0.102 | 0.061 | 0.102 | Hedgehog signaling inhibitor | |||
| 0.211 | 0.171 | 0.378 | Interleukin 2 agonist | 0.378 0.034 CID_97535 0.359 0.042 CID_154699513 | CID_97535 | |
| 0.061 | 0.022 | 0.128 | Lysophosphatidic acid 3 receptor antagonist | 0.128 0.003 CID_97535 0.055 0.028 CID_154699513 | CID_97535 | |
| 0.063 | 0.024 | 0.063 | Alpha-mannosidase inhibitor | |||
| 0.042 | 0.004 | 0.042 | Complement factor 1s inhibitor | |||
| 0.056 | 0.017 | 0.078 | AICAR transformylase inhibitor | 0.078 0.008 CID_97535 0.047 0.026 CID_154699513 | CID_97535 | |
| 0.092 | 0.053 | 0.092 | Histamine N-methyltransferase inhibitor | |||
| 0.045 | 0.007 | 0.045 | Adenosine uptake inhibitor | |||
| 0.048 | 0.01 | 0.052 | AMPA 3 receptor antagonist | 0.052 0.008 CID_97535 0.036 0.016 CID_154699513 | CID_97535 | |
| 0.054 | 0.017 | 0.054 | Glutamate (mGluR group III) antagonist | |||
| 0.203 | 0.166 | 0.288 | Transcription factor NF kappa B inhibitor | 0.288 0.101 CID_97535 | CID_97535 | |
| 0.041 | 0.004 | 0.041 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.107 | 0.071 | 0.107 | Protein kinase (CK2) alpha inhibitor | |||
| 0.047 | 0.012 | 0.047 | CF transmembrane conductance regulator antagonist | |||
| 0.04 | 0.005 | 0.04 | Complement factor 1r inhibitor | |||
| 0.066 | 0.031 | 0.066 | Carbonic anhydrase VB inhibitor | |||
| 0.04 | 0.006 | 0.04 | Integrin alpha2beta1 antagonist | |||
| 0.08 | 0.046 | 0.08 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.05 | 0.017 | 0.05 | Dihydropteroate synthase inhibitor | |||
| 0.057 | 0.024 | 0.091 | CD45 antagonist | 0.091 0.01 CID_97535 0.055 0.026 CID_154699513 | CID_97535 | |
| 0.05 | 0.017 | 0.05 | Alpha 1L adrenoreceptor agonist | |||
| 0.059 | 0.027 | 0.059 | Immunoglobulin Fc receptor antagonist | |||
| 0.096 | 0.064 | 0.096 | Xanthine oxidase inhibitor | |||
| 0.097 | 0.066 | 0.097 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.075 | 0.044 | 0.075 | Benzodiazepine agonist | |||
| 0.091 | 0.06 | 0.091 | Glutamate release inhibitor | |||
| 0.033 | 0.003 | 0.033 | Thromboxane A2 agonist | |||
| 0.052 | 0.023 | 0.052 | Mannosidase inhibitor | |||
| 0.037 | 0.009 | 0.037 | CXC chemokine 2 receptor antagonist | |||
| 0.095 | 0.069 | 0.095 | GABA C receptor rho-1 antagonist | |||
| 0.041 | 0.015 | 0.041 | Potassium channel small-conductance Ca-activated activator | |||
| 0.065 | 0.039 | 0.065 | Carbamoyl phosphate synthetase inhibitor | 0.059 0.044 CID_154699513 | ||
| 0.077 | 0.051 | 0.077 | CYP2A6 inhibitor | |||
| 0.034 | 0.009 | 0.034 | Thymidine phosphorylase inhibitor | |||
| 0.038 | 0.014 | 0.038 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.025 CID_97535 | ||
| 0.084 | 0.06 | 0.084 | Epidermal growth factor antagonist | |||
| 0.049 | 0.026 | 0.049 | CDK7/cyclin H inhibitor | |||
| 0.061 | 0.039 | 0.061 | CDK9/cyclin T1 inhibitor | |||
| 0.052 | 0.031 | 0.052 | Carbonic anhydrase XIV inhibitor | |||
| 0.035 | 0.015 | 0.035 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.026 | 0.006 | 0.026 | Kainate receptor 3 antagonist | 0.021 0.008 CID_97535 0.018 0.011 CID_154699513 | ||
| 0.05 | 0.03 | 0.05 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.072 | 0.053 | 0.197 | Catalase inhibitor | 0.197 0.016 CID_97535 0.188 0.018 CID_154699513 | CID_97535 | |
| 0.064 | 0.045 | 0.25 | Neutrophil collagenase inhibitor | 0.25 0.005 CID_97535 0.087 0.028 CID_154699513 | CID_97535 | |
| 0.096 | 0.078 | 0.159 | Factor V inhibitor | 0.159 0.015 CID_97535 0.155 0.016 CID_154699513 | CID_97535 | |
| 0.035 | 0.017 | 0.035 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.073 | 0.055 | 0.073 | Potassium channel (Tandem pore domain) blocker | |||
| 0.133 | 0.116 | 0.133 | LIM domain kinase 1 inhibitor | |||
| 0.034 | 0.017 | 0.044 | AMPA 2 receptor antagonist | 0.044 0.013 CID_97535 0.036 0.016 CID_154699513 | CID_97535 | |
| 0.031 | 0.015 | 0.031 | LFA antagonist | |||
| 0.057 | 0.041 | 0.057 | Xanthine dehydrogenase inhibitor | |||
| 0.04 | 0.024 | 0.04 | TRPM8 blocker | |||
| 0.048 | 0.032 | 0.048 | Benzodiazepine antagonist | |||
| 0.024 | 0.009 | 0.024 | Factor XIII inhibitor | |||
| 0.033 | 0.018 | 0.033 | Epoxide hydrolase 1 inhibitor | |||
| 0.03 | 0.016 | 0.03 | Estrogen-related receptor gamma antagonist | |||
| 0.036 | 0.022 | 0.036 | Fumarate hydratase inhibitor | |||
| 0.065 | 0.052 | 0.065 | Glutamate (mGluR6) antagonist | |||
| 0.235 | 0.222 | 0.235 | Calcium channel L-type activator | |||
| 0.05 | 0.038 | 0.05 | Aldose reductase inhibitor | |||
| 0.059 | 0.048 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.055 | 0.044 | 0.055 | Pregnane X receptor antagonist | |||
| 0.039 | 0.028 | 0.039 | GABA uptake inhibitor | |||
| 0.049 | 0.039 | 0.049 | CXC chemokine 1 receptor antagonist | |||
| 0.089 | 0.079 | 0.143 | Nitric-oxide synthase inhibitor | 0.143 0.026 CID_97535 | CID_97535 | |
| 0.107 | 0.096 | 0.107 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.077 | 0.067 | 0.098 | Inducible nitric-oxide synthase inhibitor | 0.098 0.038 CID_97535 | CID_97535 | |
| 0.016 | 0.005 | 0.016 | Carbonic anhydrase XI inhibitor | |||
| 0.014 | 0.004 | 0.014 | Progesterone receptor A antagonist | |||
| 0.016 | 0.005 | 0.016 | Glutamate (mGluR6) agonist | 0.012 0.008 CID_97535 | ||
| 0.033 | 0.023 | 0.033 | Purinergic P2Y2 antagonist | |||
| 0.015 | 0.006 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.05 | 0.041 | 0.05 | GABA A receptor antagonist | |||
| 0.056 | 0.047 | 0.056 | CDK2/cyclin E inhibitor | |||
| 0.019 | 0.01 | 0.019 | Complement factor 1 inhibitor | |||
| 0.023 | 0.014 | 0.023 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.051 | 0.042 | 0.11 | Maillard reaction inhibitor | 0.11 0.013 CID_97535 | CID_97535 | |
| 0.044 | 0.035 | 0.263 | Glycine transporter 2 inhibitor | 0.263 0.004 CID_97535 0.233 0.005 CID_154699513 | CID_97535 | |
| 0.018 | 0.01 | 0.018 | CC chemokine 9 receptor antagonist | |||
| 0.026 | 0.018 | 0.026 | Acid ceramidase inhibitor | |||
| 0.028 | 0.02 | 0.028 | CDK4/cyclin D3 inhibitor | |||
| 0.017 | 0.009 | 0.017 | CDK2/cyclin A3 inhibitor | |||
| 0.027 | 0.02 | 0.027 | Uridine phosphorylase inhibitor | |||
| 0.051 | 0.044 | 0.051 | GABA receptor antagonist | |||
| 0.028 | 0.023 | 0.028 | MAP3K8 inhibitor | |||
| 0.045 | 0.04 | 0.045 | Thromboxane A2 antagonist | |||
| 0.044 | 0.039 | 0.044 | CC chemokine 4 receptor antagonist | |||
| 0.012 | 0.007 | 0.012 | Thromboxane agonist | |||
| 0.048 | 0.043 | 0.048 | Aconitate hydratase inhibitor | |||
| 0.022 | 0.017 | 0.022 | Isoleucine-tRNA ligase inhibitor | |||
| 0.02 | 0.015 | 0.02 | Imidazoline I1 receptor antagonist | |||
| 0.025 | 0.021 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.042 | 0.038 | 0.042 | Carbonic anhydrase VII inhibitor | |||
| 0.047 | 0.045 | 0.047 | Thromboxane antagonist | |||
| 0.015 | 0.012 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.03 | 0.028 | 0.03 | Calcium release-activated channel blocker | |||
| 0.016 | 0.014 | 0.016 | Alpha 2a adrenoreceptor agonist | |||
| 0.05 | 0.049 | 0.05 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.05 | 0.049 | 0.05 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.106 | 0.106 | 0.112 | Antibacterial (Helicobacter pylori) | 0.112 0.094 CID_97535 | CID_97535 | |
| 0.031 | 0.035 | 0.111 | Factor XIIIa inhibitor | 0.111 0.005 CID_97535 0.036 0.028 CID_154699513 | CID_97535 | |
| 0.043 | 0.048 | 0.08 | Bombesin 2 receptor antagonist | 0.08 0.017 CID_97535 0.063 0.022 CID_154699513 | CID_97535 | |
| 0.15 | 0.156 | 0.296 | Vasodilator | 0.229 0.083 CID_97535 0.296 0.049 CID_154699513 | CID_154699513 | |
| 0.053 | 0.065 | 0.068 | Caspase 9 inhibitor | 0.068 0.033 CID_97535 0.064 0.04 CID_154699513 | CID_97535 | |
| 0.062 | 0.074 | 0.171 | Metalloproteinase-9 inhibitor | 0.171 0.012 CID_97535 | CID_97535 | |
| 0.026 | 0.054 | 0.232 | Toll-Like receptor 2 agonist | 0.232 0.005 CID_97535 0.205 0.007 CID_154699513 | CID_97535 | |
| 0.174 | 0.202 | 0.331 | Insulysin inhibitor | 0.331 0.042 CID_97535 0.277 0.074 CID_154699513 | CID_97535 | |
| 0.104 | 0.139 | 0.304 | Phospholipase A2 inhibitor | 0.304 0.013 CID_97535 0.16 0.065 CID_154699513 | CID_97535 | |
| 0.029 | 0.065 | 0.138 | Ribonucleoside-diphosphate reductase inhibitor | 0.138 0.013 CID_97535 0.078 0.025 CID_154699513 | CID_97535 | |
| 0.017 | 0.054 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.016 CID_97535 | CID_97535 | |
| 0.028 | 0.068 | 0.131 | Ribonucleotide reductase inhibitor | 0.131 0.015 CID_97535 0.079 0.027 CID_154699513 | CID_97535 | |
| 0.056 | 0.096 | 0.202 | Metalloproteinase-2 inhibitor | 0.202 0.01 CID_97535 0.076 0.057 CID_154699513 | CID_97535 | |
| 0.05 | 0.091 | 0.151 | Aminopeptidase I inhibitor | 0.151 0.012 CID_97535 0.142 0.014 CID_154699513 | CID_97535 | |
| 0.013 | 0.064 | 0.035 | Lysine carboxypeptidase inhibitor | 0.033 0.014 CID_97535 0.035 0.013 CID_154699513 | CID_154699513 | |
| 0.026 | 0.078 | 0.101 | Matrix metalloproteinase 1 inhibitor | 0.101 0.013 CID_97535 | CID_97535 | |
| 0.026 | 0.083 | 0.074 | Neuropeptide agonist | 0.074 0.034 CID_97535 0.049 0.043 CID_154699513 | CID_97535 | |
| 0.042 | 0.114 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | 0.067 0.04 CID_97535 | CID_97535 | |
| 0.021 | 0.097 | 0.051 | Membrane dipeptidase inhibitor | 0.051 0.015 CID_97535 0.043 0.023 CID_154699513 | CID_97535 | |
| 0.005 | 0.081 | 0.021 | Aminopeptidase A inhibitor | 0.021 0.01 CID_97535 0.02 0.011 CID_154699513 | CID_97535 | |
| 0.118 | 0.195 | 0.251 | Free radical scavenger | 0.251 0.068 CID_97535 | CID_97535 | |
| 0.02 | 0.102 | 0.095 | Antimetabolite | 0.095 0.017 CID_97535 0.057 0.027 CID_154699513 | CID_97535 | |
| 0.019 | 0.104 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.024 CID_154699513 | CID_154699513 | |
| 0.064 | 0.156 | 0.17 | Histone deacetylase class III inhibitor | 0.17 0.031 CID_97535 0.115 0.074 CID_154699513 | CID_97535 | |
| 0.031 | 0.125 | 0.128 | Matrix metalloproteinase inhibitor | 0.128 0.018 CID_97535 | CID_97535 | |
| 0.004 | 0.105 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 CID_97535 | CID_97535 | |
| 0.062 | 0.163 | 0.143 | Proteasome inhibitor | 0.143 0.051 CID_97535 0.133 0.056 CID_154699513 | CID_97535 | |
| 0.035 | 0.14 | 0.061 | DNA helicase inhibitor | 0.061 0.026 CID_97535 | CID_97535 | |
| 0.006 | 0.113 | 0.056 | Arginase inhibitor | 0.037 0.025 CID_97535 0.056 0.012 CID_154699513 | CID_154699513 | |
| 0.088 | 0.199 | 0.119 | Vanilloid 1 agonist | 0.119 0.09 CID_97535 0.115 0.101 CID_154699513 | CID_97535 | |
| 0.027 | 0.16 | 0.086 | Carbonic anhydrase stimulant | 0.086 0.023 CID_97535 | CID_97535 | |
| 0.025 | 0.159 | 0.037 | Integrin alpha1beta1 antagonist | 0.037 0.03 CID_97535 | CID_97535 | |
| 0.13 | 0.284 | 0.27 | Antithrombotic | 0.27 0.111 CID_97535 | CID_97535 | |
| 0.036 | 0.191 | 0.083 | Ornithine decarboxylase inhibitor | 0.083 0.064 CID_97535 | CID_97535 | |
| 0.052 | 0.217 | 0.121 | Mucolytic | 0.121 0.054 CID_97535 0.117 0.057 CID_154699513 | CID_97535 | |
| 0.058 | 0.234 | 0.147 | Toll-Like receptor 2 antagonist | 0.147 0.054 CID_97535 0.14 0.06 CID_154699513 | CID_97535 | |
| 0.073 | 0.265 | 0.521 | Interleukin antagonist | 0.521 0.018 CID_97535 0.4 0.031 CID_154699513 | CID_97535 | |
| 0.062 | 0.287 | 0.22 | Insulin sensitizer | 0.22 0.055 CID_97535 | CID_97535 | |
| 0.03 | 0.266 | 0.091 | Expectorant | 0.09 0.081 CID_97535 0.091 0.08 CID_154699513 | CID_154699513 | |
| 0.049 | 0.309 | 0.185 | Hematopoietic | 0.185 0.011 CID_97535 0.156 0.014 CID_154699513 | CID_97535 | |
| 0.038 | 0.311 | 0.134 | Protein-tyrosine phosphatase inhibitor | 0.134 0.097 CID_97535 | CID_97535 | |
| 0.016 | 0.29 | 0.042 | Farnesyltransferase inhibitor | 0.042 0.038 CID_154699513 | CID_154699513 | |
| 0.031 | 0.308 | 0.09 | Chymotrypsin inhibitor | 0.09 0.044 CID_97535 0.076 0.059 CID_154699513 | CID_97535 | |
| 0.015 | 0.293 | 0.047 | Bombesin antagonist | 0.047 0.034 CID_97535 0.044 0.04 CID_154699513 | CID_97535 | |
| 0.041 | 0.35 | 0.105 | Transcription factor NF kappa B stimulant | 0.105 0.034 CID_97535 0.093 0.046 CID_154699513 | CID_97535 | |
| 0.011 | 0.32 | 0.057 | Aminopeptidase N inhibitor | 0.057 0.026 CID_97535 0.051 0.031 CID_154699513 | CID_97535 | |
| 0.026 | 0.361 | 0.06 | Trypsin inhibitor | 0.06 0.046 CID_97535 | CID_97535 | |
| 0.027 | 0.364 | 0.079 | Cell adhesion molecule inhibitor | 0.079 0.055 CID_97535 | CID_97535 | |
| 0.045 | 0.384 | 0.215 | Histone deacetylase SIRT1 inhibitor | 0.215 0.025 CID_97535 0.183 0.038 CID_154699513 | CID_97535 | |
| 0.015 | 0.363 | 0.078 | Aminopeptidase microsomal inhibitor | 0.078 0.026 CID_97535 0.069 0.032 CID_154699513 | CID_97535 | |
| 0.004 | 0.405 | 0.035 | Cholecystokinin antagonist | 0.035 0.032 CID_97535 | CID_97535 | |
| 0.015 | 0.42 | 0.075 | Thrombin inhibitor | 0.075 0.048 CID_97535 | CID_97535 | |
| 0.009 | 0.415 | 0.094 | Glucagon-like peptide 1 agonist | 0.094 0.025 CID_97535 0.094 0.025 CID_154699513 | CID_154699513 | |
| 0.024 | 0.453 | 0.069 | Adenine nucleotide translocase inhibitor | 0.068 0.017 CID_97535 0.069 0.016 CID_154699513 | CID_154699513 | |
| 0.004 | 0.437 | 0.076 | Integrin antagonist | 0.076 0.02 CID_97535 | CID_97535 | |
| 0.02 | 0.474 | 0.277 | Chelator | 0.277 0.013 CID_97535 0.142 0.039 CID_154699513 | CID_97535 | |
| 0.02 | 0.483 | 0.103 | Factor XII inhibitor | 0.103 0.035 CID_97535 0.102 0.036 CID_154699513 | CID_97535 | |
| 0.013 | 0.486 | 0.063 | Cathepsin B inhibitor | 0.063 0.033 CID_97535 0.054 0.042 CID_154699513 | CID_97535 | |
| 0.033 | 0.52 | 0.143 | Platelet adhesion inhibitor | 0.143 0.114 CID_154699513 | CID_154699513 | |
| 0.027 | 0.517 | 0.159 | Cell adhesion inhibitor | 0.124 0.062 CID_97535 0.159 0.041 CID_154699513 | CID_154699513 | |
| 0.004 | 0.559 | 0.031 | Caspase 2 inhibitor | 0.031 0.022 CID_97535 0.029 0.024 CID_154699513 | CID_97535 | |
| 0.008 | 0.591 | 0.054 | Erythropoietin receptor agonist | 0.054 0.02 CID_97535 0.054 0.02 CID_154699513 | CID_154699513 | |
| 0.049 | 0.667 | 0.334 | Apoptosis antagonist | 0.334 0.064 CID_97535 0.258 0.119 CID_154699513 | CID_97535 | |
| 0.005 | 0.639 | 0.046 | Integrin alpha5beta1 antagonist | 0.046 0.022 CID_97535 0.043 0.026 CID_154699513 | CID_97535 | |
| 0.017 | 0.653 | 0.216 | Antioxidant | 0.216 0.104 CID_97535 | CID_97535 | |
| 0.009 | 0.659 | 0.369 | Purinergic P2X2 antagonist | 0.369 0.001 CID_154699513 | CID_154699513 | |
| 0.004 | 0.701 | 0.091 | Purinergic P2X3 antagonist | 0.091 0.005 CID_154699513 | CID_154699513 | |
| 0.031 | 0.747 | 0.13 | Folate antagonist | 0.13 0.032 CID_97535 0.113 0.045 CID_154699513 | CID_97535 | |
| 0.012 | 0.738 | 0.388 | Angiogenesis stimulant | 0.388 0.024 CID_97535 0.363 0.029 CID_154699513 | CID_97535 | |
| 0.003 | 0.732 | 0.03 | Bradykinin B2 receptor agonist | 0.03 0.019 CID_97535 0.03 0.018 CID_154699513 | CID_154699513 | |
| 0.024 | 0.769 | 0.23 | Immunomodulator | 0.23 0.132 CID_97535 | CID_97535 | |
| 0.003 | 0.749 | 0.075 | Leukotriene A4 hydrolase inhibitor | 0.075 0.01 CID_97535 0.059 0.016 CID_154699513 | CID_97535 | |
| 0.007 | 0.773 | 0.102 | Aminoacyl-tRNA synthetase inhibitor | 0.102 0.043 CID_97535 0.095 0.051 CID_154699513 | CID_97535 | |
| 0.009 | 0.784 | 0.046 | Cathepsin F inhibitor | 0.046 0.019 CID_97535 0.044 0.023 CID_154699513 | CID_97535 | |
| 0.007 | 0.789 | 0.137 | Protease inhibitor | 0.137 0.037 CID_97535 0.116 0.051 CID_154699513 | CID_97535 | |
| 0.009 | 0.804 | 0.041 | Glutamate (mGluR8) antagonist | 0.04 0.017 CID_97535 0.041 0.016 CID_154699513 | CID_154699513 | |
| 0.013 | 0.826 | 0.116 | Nav1.4 sodium channel blocker | 0.116 0.055 CID_97535 0.108 0.065 CID_154699513 | CID_97535 | |
| 0.013 | 0.844 | 0.054 | Cathepsin E inhibitor | 0.054 0.051 CID_97535 | CID_97535 | |
| 0.047 | 0.886 | 0.217 | MAP kinase kinase 3 inhibitor | 0.217 0.079 CID_97535 | CID_97535 | |
| 0.017 | 0.873 | 0.218 | Hepatoprotectant | 0.218 0.055 CID_97535 0.199 0.065 CID_154699513 | CID_97535 | |
| 0.002 | 0.868 | 0.051 | Complement C3a chemotactic receptor antagonist | 0.05 0.026 CID_97535 0.051 0.026 CID_154699513 | CID_154699513 | |
| 0.006 | 0.883 | 0.371 | Thrombolytic | 0.371 0.014 CID_97535 0.349 0.017 CID_154699513 | CID_97535 | |
| 0.001 | 0.891 | 0.013 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.013 0.011 CID_97535 | CID_97535 | |
| 0.006 | 0.898 | 0.085 | Sirtuin 1 inhibitor | 0.085 0.031 CID_97535 0.082 0.034 CID_154699513 | CID_97535 | |
| 0.005 | 0.911 | 0.235 | Anticoagulant | 0.235 0.042 CID_97535 0.177 0.063 CID_154699513 | CID_97535 | |
| 0.005 | 0.914 | 0.36 | Platelet antagonist | 0.36 0.036 CID_97535 0.343 0.04 CID_154699513 | CID_97535 | |
| 0.004 | 0.925 | 0.04 | Growth hormone release inhibitor | 0.038 0.035 CID_97535 0.04 0.031 CID_154699513 | CID_154699513 | |
| 0.006 | 0.933 | 0.122 | Bone formation stimulant | 0.122 0.083 CID_97535 0.114 0.091 CID_154699513 | CID_97535 | |
| 0.003 | 0.948 | 0.087 | Selectin antagonist | 0.087 0.033 CID_97535 0.075 0.039 CID_154699513 | CID_97535 | |
| 0.005 | 0.954 | 0.041 | Neurokinin 2 agonist | 0.041 0.03 CID_97535 0.041 0.03 CID_154699513 | CID_154699513 | |
| 0.004 | 0.963 | 0.044 | Neurotensin receptor antagonist | 0.044 0.032 CID_97535 0.041 0.035 CID_154699513 | CID_97535 | |
| 0.002 | 0.971 | 0.051 | Carbonic anhydrase I stimulant | 0.051 0.016 CID_97535 0.039 0.025 CID_154699513 | CID_97535 | |
| 0.002 | 0.979 | 0.029 | Protocollagen prolyl hydroxylase inhibitor | 0.029 0.017 CID_97535 0.026 0.021 CID_154699513 | CID_97535 | |
| 0.003 | 0.983 | 0.043 | Endothelin-converting enzyme inhibitor | 0.043 0.035 CID_97535 | CID_97535 | |
| 0.002 | 0.985 | 0.073 | Angiotensin-converting enzyme inhibitor | 0.07 0.019 CID_97535 0.073 0.018 CID_154699513 | CID_154699513 | |
| 0.008 | 0.997 | 0.291 | Growth hormone agonist | 0.288 0.035 CID_97535 0.291 0.034 CID_154699513 | CID_154699513 | |
| 0.006 | 0.996 | 0.41 | Sodium/bile acid cotransporter inhibitor | 0.41 0.014 CID_97535 0.4 0.017 CID_154699513 | CID_97535 | |
| 0.003 | 0.996 | 0.058 | Carbonic anhydrase II stimulant | 0.058 0.026 CID_97535 0.052 0.036 CID_154699513 | CID_97535 | |
| 0.002 | 0.996 | 0.056 | Bombesin 1 receptor agonist | 0.056 0.046 CID_97535 0.056 0.046 CID_154699513 | CID_154699513 | |
| 0.001 | 0.995 | 0.065 | GP IIb/IIIa receptor antagonist | 0.065 0.026 CID_97535 0.049 0.034 CID_154699513 | CID_97535 | |
| 0 | 0.995 | 0.022 | Aminopeptidase P inhibitor | 0.022 0.018 CID_97535 0.022 0.018 CID_154699513 | CID_154699513 | |
| 0.002 | 0.997 | 0.08 | Somatostatin 1 agonist | 0.077 0.055 CID_97535 0.08 0.051 CID_154699513 | CID_154699513 | |
| 0.002 | 0.997 | 0.04 | Cholecystokinin B agonist | 0.04 0.023 CID_97535 0.04 0.023 CID_154699513 | CID_154699513 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |